Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Skin ulcer study backs LAM's would gel:

This article was originally published in Clinica

Executive Summary

LAM Pharmaceutical says that a study of its wound healing gel LAM IMP has shown positive results. The 24-week study showed a healing rate of 88% in 53 hard-to-heal skin ulcers treated with gel. All the patients had ulcers that had failed to respond to other forms of treatment for at least four weeks before they were enrolled in the study, notes the Lewiston, New York firm. The findings are scheduled for presentation at the Annual Symposium on Advanced Wound Care meeting in Baltimore, Maryland, next month.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT065034

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel